GreenLight Biosciences Acquires Bayer's topical RNA Intellectual Property portfolio
Autor: | PR Newswire |
---|---|
Zdroj: | PR Newswire US. 05/20/2021. |
Abstrakt: | BOSTON, May 20, 2021 /PRNewswire/ -- GreenLight Biosciences today announced that they have acquired rights to portions of Bayer's topical RNA Intellectual Property portfolio. These assets include bee health capabilities to protect against Varroa mites, a major threat to honeybees. [ABSTRACT FROM PUBLISHER] |
Databáze: | Regional Business News |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |